HGF gene therapy attenuates renal allograft scarring by preventing the profibrotic inflammatory-induced mechanisms
- 1 July 2006
- journal article
- Published by Elsevier in Kidney International
- Vol. 70 (2) , 265-274
- https://doi.org/10.1038/sj.ki.5001510
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Hepatocyte Growth Factor Suppresses Vascular Endothelial Growth Factor-Induced Expression of Endothelial ICAM-1 and VCAM-1 by Inhibiting the Nuclear Factor-κB PathwayCirculation Research, 2005
- A Novel Mechanism by which Hepatocyte Growth Factor Blocks Tubular Epithelial to Mesenchymal TransitionJournal of the American Society of Nephrology, 2005
- Safety Evaluation of Clinical Gene Therapy Using Hepatocyte Growth Factor to Treat Peripheral Arterial DiseaseHypertension, 2004
- Hepatocyte growth factor in kidney fibrosis: therapeutic potential and mechanisms of actionAmerican Journal of Physiology-Renal Physiology, 2004
- Hepatocyte growth factor attenuates cerebral ischemia-induced learning dysfunctionBiochemical and Biophysical Research Communications, 2004
- Living kidney donors and hypoxia-inducible factor-1αTransplantation, 2003
- Ameliorative Effect of Hepatocyte Growth Factor on Glycerol-Induced Acute Renal Failure with Acute Tubular NecrosisNephron, 2002
- Electrochemotherapy in Primary and Metastatic Skin TumorsArchives of Medical Research, 2001
- Reciprocal balance of hepatocyte growth factor and transforming growth factor-β1 in renal fibrosis in miceKidney International, 2000
- Early protocol renal allograft biopsies and graft outcomeKidney International, 1997